{"id":"W2996929715","doi":"10.1002/prp2.555","title":"Rituximab utilization for approved and off‐label nononcology indications and patients’ experiences with the Patient Alert Card","year":2020,"lang":"en","type":"article","venue":"Pharmacology Research & Perspectives","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"Roche","keywords":"Rituximab; Medicine; Progressive multifocal leukoencephalopathy; Microscopic polyangiitis; Granulomatosis with polyangiitis; Retrospective cohort study; Internal medicine; Natalizumab; Pediatrics; Vasculitis; Immunology; Multiple sclerosis; Lymphoma; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001860054,0.0001128114,0.0001460406,0.0006426374,0.0003262967,0.0009561276,0.0002485152,0.0003934508,0.003101184],"category_scores_gemma":[0.009442108,0.0001486622,0.0004073344,0.0007424576,0.000278085,0.0007750497,0.0006820926,0.0006551282,0.0002787109],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006102191,"about_ca_system_score_gemma":0.0005392313,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002562209,"about_ca_topic_score_gemma":0.002982625,"domain_scores_codex":[0.9976909,0.001008523,0.0004498607,0.0002095309,0.0003628703,0.0002784076],"domain_scores_gemma":[0.9828889,0.00318751,0.01217949,0.0002918578,0.0004286891,0.00102348],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000126194,0.00007999566,0.9914881,0.00003441982,0.00003106993,0.00005387152,0.0003404025,0.00003200579,0.00006138343,0.00003972116,0.0004759471,0.007236835],"study_design_scores_gemma":[0.00001612677,0.0002618943,0.995401,0.00007554908,0.00004535113,0.0007432441,0.001013796,0.0002183768,0.0001759174,0.00003762617,0.002000427,0.00001071855],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9977623,0.0005055393,0.00006531643,0.0002612286,0.00000695521,0.00001554347,0.0003337837,0.000003645825,0.001045752],"genre_scores_gemma":[0.9990696,0.0002833348,0.00008608066,0.0001569341,0.00001551979,0.00001197294,0.0001911452,0.00000121964,0.0001842388],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003101184,"threshold_uncertainty_score":0.01037443,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1045231716364987,"score_gpt":0.4204027257736874,"score_spread":0.3158795541371887,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}